The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world analysis of patient characteristics and outcomes among patients with metastatic colorectal cancer receiving trifluridine/tipiracil (FTD/TPI) plus bevacizumab versus FTD/TPI monotherapy.
 
Joleen M. Hubbard
Employment - Allina Health Cancer Institute
Consulting or Advisory Role - Bayer (Inst); BeiGene (Inst); Incyte (Inst); Incyte (Inst); Merck; Seattle Genetics/Astellas; Taiho Oncology (Inst)
Research Funding - Bayer (Inst); G1 Therapeutics (Inst); Incyte (Inst); Merck (Inst); Pfizer (Inst); Pionyr (Inst); Seagen (Inst); Senhwa Biosciences (Inst); Taiho Pharmaceutical (Inst); Translational Research in Oncology (Inst); Treos Bio (Inst); Trovagene (Inst)
 
Lulu K. Lee
Employment - Cerner Enviza
Stock and Other Ownership Interests - Oracle Corporation
 
Jay L. Grisolano
Employment - Cerner Enviza
Stock and Other Ownership Interests - AstraZeneca; Bristol-Myers Squibb; Daiichi Sankyo; Pfizer
 
Kacper Perkowski
Employment - Cerner Enviza
Travel, Accommodations, Expenses - Cerner Enviza
Other Relationship - Cerner Enviza
 
Tehseen Salimi
Employment - Taiho Oncology
 
Reza Kazerooni
Employment - Taiho Oncology
 
Robert S. Epstein
Employment - Epstein Health
Leadership - Diadem; Fate Therapeutics; Illumina; Tasso; Veracyte
Stock and Other Ownership Interests - Cigna; Fate Therapeutics; Illumina; Veracyte
Consulting or Advisory Role - Halozyme; Janssen; Taiho Oncology
Research Funding - Taiho Oncology